One breath, one scan: could this replace painful liver biopsies?
NCT ID NCT05384652
First seen Mar 31, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study is testing a new, non-invasive MRI technique that can measure liver fat, fatty acid makeup, and scarring all at once during a single 14-second breath-hold. The goal is to see if this scan can accurately diagnose non-alcoholic steatohepatitis (NASH) without needing a liver biopsy. The study will involve 120 people with fatty liver disease and 20 healthy volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Chinese University of Hong Kong, Prince of Wale Hospital
Hong Kong, Shatin, Hong Kong
Conditions
Explore the condition pages connected to this study.